Showing recent highlights
Medications
PubMed · December 1, 2026
This research looked at two blood thinners — Eliquis (apixaban) and Xarelto (rivaroxaban) — compared to an older blood thinner called warfarin, in people who have atrial fibrillation (an irregular heartbeat that raises stroke risk) and are on dialysis due to serious kidney disease. The study found that Eliquis and Xarelto were linked to lower rates of dangerous bleeding, stroke, and death compared to warfarin in this group, which is a meaningful safety and effectiveness update for a population that has historically been very difficult to treat. This adds to a growing picture suggesting these newer blood thinners may be a safer option than warfarin for people in this specific situation, though your doctor would weigh all the details before making any decision.
Ask your doctor: Ask the doctor whether apixaban might be safer than warfarin for preventing blood clots if the patient have atrial fibrillation and kidney problems.
What's New
PubMed · December 1, 2026
Researchers found something surprising: smartwatches and wearable heart monitors were very good at spotting atrial fibrillation — an irregular heartbeat that can raise the risk of serious heart problems like heart attacks or strokes — but finding more cases didn't actually seem to lead to better health outcomes for people screened. In fact, continuous monitoring nearly tripled the number of diagnoses and doubled the use of blood-thinning medications, yet the extra treatment didn't clearly prevent harm, raising the question of whether some of those diagnoses may not have needed treatment at all — a concept called 'overdiagnosis,' meaning the condition was detected but may never have caused problems. Someday this research might help doctors figure out who truly benefits from wearable heart screening, rather than putting more people through treatment they may not need. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether using a smartwatch or fitness tracker to check the patient's heart rhythm could lead to finding an irregular heartbeat that might not actually need treatment.
Guidelines
ScienceDaily · July 22, 2026
A review by the American Heart Association found that up to 400 milligrams of caffeine a day — about three to five cups of regular black coffee — appears to be generally safe for the heart and may even be linked to lower chances of heart disease, stroke, and Type 2 diabetes. However, the source of caffeine matters a lot: highly concentrated energy drinks and shots were linked to raised blood pressure and irregular heartbeats, which can be dangerous. People with heart failure or other heart conditions may want to talk with their doctor before making changes to their caffeine habits.
What's New
PubMed · July 21, 2026
A study found that older adults (ages 60–85) with atrial fibrillation — an irregular heartbeat that can cause symptoms like fatigue, shortness of breath, and palpitations — who followed a low-calorie diet and received behavioral support lost significantly more weight than those who received standard care, and researchers were looking at whether this helped reduce AF symptoms. This matters because some doctors have worried that weight loss in older people might lead to frailty (becoming physically weaker and more vulnerable), so understanding whether it's safe and helpful for this age group could be important for how AF is managed. This is early research and hasn't yet changed treatment guidelines.
Lifestyle
JAMA · July 21, 2026
A study examined whether people with atrial fibrillation — an irregular heartbeat — could benefit from eating a low-calorie diet combined with regular behavioral coaching and support sessions. Researchers wanted to find out if this combination helped with weight loss in a safe way for older adults who were also overweight. The study looked specifically at whether losing weight through these structured steps made a meaningful difference for people managing this heart condition.
Lifestyle
JAMA · July 21, 2026
A study looked at what happened when older adults with a heart rhythm problem called atrial fibrillation — where the heart beats irregularly — followed a low-calorie diet along with behavioral support (like coaching and guidance) for 8 months. Researchers wanted to see whether losing weight this way would reduce the uncomfortable symptoms that come with an irregular heartbeat, compared to people who just received their usual medical care. The study focused specifically on people who were overweight or obese and had a lasting, ongoing form of this heart rhythm problem.
What's New
The Lancet · July 15, 2026
Researchers found that people with atrial fibrillation — an irregular heartbeat that raises the risk of stroke — face a tricky balancing act if they also need a procedure to open blocked heart arteries. They need blood-thinning medication to prevent strokes, but also separate medications to keep the newly placed artery stent working properly, and combining these raises the risk of dangerous bleeding. This is early research and hasn't yet changed treatment guidelines.
What's New
The Lancet · July 15, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat condition) who had a procedure to open blocked heart arteries, taking a combination of two blood-thinning medications for just 1 month — instead of the usual 12 months — worked just as well at preventing serious complications like death, heart attacks, or strokes, while also causing significantly less bleeding. Bleeding is a major concern with blood thinners, so finding a shorter course that keeps people safe while reducing that risk is meaningful for this group of patients. This is early research and hasn't yet changed treatment guidelines.
What's New
ScienceDaily · July 14, 2026
A press release highlights a finding that exercise doesn't just make the heart stronger — it also changes the way the nerves controlling the heart work, almost like rewiring the system. For people with atrial fibrillation (an irregular heartbeat), this could be meaningful because those same nerves play a role in keeping the heart's rhythm steady. Researchers believe this discovery might one day help doctors tailor treatments more specifically to each person's heart condition.
What's New
PubMed · July 14, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat) who also had chronic kidney disease (meaning their kidneys weren't filtering blood as well as they should), starting heart rhythm treatment early was linked to a notably lower rate of serious heart problems like heart attacks or strokes compared to those who received standard care — and the benefit appeared even stronger than in people without kidney disease. This matters because people with kidney disease are often considered a harder-to-treat group, so finding that early rhythm treatment may still help them is an encouraging sign. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 10, 2026
Researchers found that adding a procedure called left atrial appendage electrical isolation — which targets an extra area of the heart involved in irregular rhythms — to a standard treatment helped reduce the chances of atrial fibrillation (an irregular heartbeat) coming back. The study looked at results from 3,425 patients and found that combining the two approaches worked better than the standard treatment alone. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 10, 2026
Researchers found that people diagnosed with atrial fibrillation — an irregular heartbeat condition — face meaningful long-term risks of serious complications, with heart failure being the most common, followed by stroke, heart-related death, and heart attacks; encouragingly, rates of stroke and some other problems have declined over time, though heart failure rates have not dropped in the same way. This matters because it helps doctors and researchers better understand which complications to watch for most closely in people living with atrial fibrillation. This is early research and hasn't yet changed treatment guidelines.
What's New
JAMA · July 7, 2026
Researchers found that certain common food preservatives — ingredients added to packaged foods to keep them fresh longer — may be linked to high blood pressure and serious heart problems like heart attacks or strokes. This could matter for people with high blood pressure, since it suggests that everyday food choices, not just salt or fat, might play a role in heart health. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 7, 2026
A study found that people with atrial fibrillation (an irregular heartbeat that raises stroke risk) and stable coronary artery disease (narrowed heart arteries) who took a blood-thinning medication called edoxaban alone had significantly fewer harmful health events over 12 months compared to those who took edoxaban combined with an antiplatelet drug (a medication like aspirin that helps prevent blood clots). Most of the difference came from bleeding, which happened much more often in the combination group, while rates of serious heart problems like heart attacks or strokes and death were similar between the two groups. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient might do better taking just edoxaban alone rather than edoxaban plus aspirin or another blood thinner, since the patient has both atrial fibrillation and heart disease.
What's New
PubMed · July 6, 2026
Researchers found that a small implanted device called the AnchorMan — designed to block off a tiny pouch in the heart called the left atrial appendage, where dangerous clots often form in people with atrial fibrillation (an irregular heartbeat) — worked just as well as a similar, already-established device called the Watchman at reducing the risk of stroke over 12 months. Both devices successfully sealed off that pouch in all patients tested, and serious complications were rare with either option. This matters because both devices offer an alternative for people with atrial fibrillation who cannot safely take long-term blood thinners. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient might be a good candidate for left atrial appendage closure with the AnchorMan device as an alternative to taking blood thinners to prevent stroke from atrial fibrillation.
What's New
PubMed · July 3, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat) who underwent a procedure called ablation — where doctors use energy to correct the abnormal heart rhythm — staying on blood thinners afterward may significantly lower the risk of stroke in those considered higher-risk, based on a scoring system doctors use to measure stroke risk factors like age, high blood pressure, and heart failure. However, continuing blood thinners also came with a meaningfully higher chance of serious bleeding, so the decision involves real trade-offs that depend on each person's individual health profile. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should continue taking blood thinner medication after their atrial fibrillation ablation procedure, especially based on their CHA2DS2-VASc score.
What's New
PubMed · July 1, 2026
Researchers found that people with atrial fibrillation (an irregular heartbeat) who take blood thinners called DOACs — medications like Eliquis or Xarelto used to prevent strokes — face a higher risk of serious bleeding if they have certain health conditions, including cancer, heart failure, a history of heart attack, or use of certain psychiatric medications. This large analysis of nearly one million patients confirmed known risk factors like older age and a history of bleeding, but also spotlighted several conditions that hadn't been as closely watched before. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that people with atrial fibrillation — an irregular heartbeat — who were treated with medication to control their heart rhythm were more likely to have their irregular heartbeat return compared to those who had a procedure called catheter ablation, where a doctor uses heat or cold energy to correct the problem area in the heart. The study also found a possible link between rhythm-control medications and a higher risk of death, though the numbers were small enough that this finding isn't yet certain. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether catheter ablation might work better than antiarrhythmic drugs like flecainide or sotalol at controlling the patient's heart rhythm.
What's New
PubMed · July 1, 2026
Researchers found that a procedure called catheter ablation — where doctors use a thin, flexible tube to deliver energy to the heart to correct an irregular heartbeat — was linked to fewer serious complications than medications typically used to manage atrial fibrillation (an irregular heart rhythm). Across 24 studies involving more than 6,600 people, those who had catheter ablation were less likely to experience serious problems, unexpected hospital stays, or serious heart problems like heart attacks or strokes. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that a new type of catheter — a tool doctors use to treat atrial fibrillation (an irregular heartbeat) by delivering energy to specific spots in the heart — completed the procedure faster than the standard tool currently in use. The study also hinted that combining the standard treatment with additional targeted energy applications might work better than the standard treatment alone, though the groups studied were small and the difference wasn't definitive. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that among people with an undetected, silent form of irregular heartbeat (called subclinical atrial fibrillation — meaning it causes no obvious symptoms and was only picked up by a small implanted heart monitor), a blood-thinning medication called apixaban reduced the chance of having a stroke far more than aspirin did, with about 9 times fewer strokes in that group. People in this situation had a notably higher stroke rate than those whose irregular heartbeat was spotted by other implanted heart devices like pacemakers, which suggests the monitor may be catching a higher-risk group that could benefit more from stronger blood-thinning treatment. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether apixaban would be better than aspirin for preventing stroke in the patient, given that the patient has an implantable cardiac monitor that detected irregular heartbeats.
What's New
PubMed · July 1, 2026
Researchers found that for people with a type of irregular heartbeat called atrial fibrillation (AF) — where the heart beats unpredictably and can cause serious health risks — a procedure called catheter ablation (which uses heat or cold energy to correct the electrical signals causing the problem) was about twice as effective as medication at preventing the condition from getting worse over time. The study also found that patients who didn't experience worsening of their AF had fewer serious outcomes like death or hospitalizations related to heart problems. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
A study found that colchicine — a medication that's been used for decades to treat gout and inflammation — may help protect people with coronary artery disease (a condition where the heart's blood vessels become narrowed or blocked) from serious heart problems like heart attacks or strokes. Researchers found that taking a low dose (0.5 mg once daily) for more than six months appeared to preserve that heart-protective benefit while the risk of stomach and digestive side effects, which were a concern at higher doses, became much less of an issue. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether colchicine might help reduce the patient's risk of another heart attack or stroke, and whether the potential stomach problems from taking it would be worth that benefit.
What's New
PubMed · July 1, 2026
Researchers found that a newer imaging approach used during a heart procedure called catheter ablation — where doctors use heat or cold energy to correct the irregular heartbeat known as atrial fibrillation — appears to be just as safe as the standard method. The standard method, which involves threading a small ultrasound probe down the throat, can be uncomfortable and often requires deeper sedation, while the newer approach keeps everything inside the heart through a small tube in a blood vessel. The two methods had similar rates of serious complications like stroke or bleeding, though the newer approach did slightly reduce the patient's exposure to X-ray imaging during the procedure. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · July 1, 2026
Researchers found that a procedure called pulsed field ablation — a newer technique that uses electrical pulses to correct the irregular heart rhythm known as atrial fibrillation — worked about as well in patients aged 75 and older as it did in younger patients, with similar success rates for keeping the heart in a normal rhythm afterward. However, older patients were about twice as likely to experience complications during or after the procedure, such as stroke, a collection of blood around the heart (called cardiac tamponade), or nerve issues. This is early research and hasn't yet changed treatment guidelines.
Guidelines
PubMed (Guideline Reviews) · June 29, 2026
According to the American Heart Association/American Stroke Association (AHA/ASA) and the European Stroke Organisation (ESO) guidelines, people who have had a stroke caused by a blood clot should receive a carefully personalized prevention plan — not just a one-size-fits-all approach — because the right treatment depends heavily on what caused their stroke in the first place. For example, guidelines recommend different blood-thinning strategies depending on whether the stroke was linked to an irregular heartbeat (called atrial fibrillation), a clot from an unknown source, or other causes, and they also call for keeping 'bad' cholesterol (LDL) as low as possible using combination treatments when needed. This matters because strokes can happen again, and matching each person's treatment to their specific situation gives the best chance of preventing another one.
Ask your doctor: Ask the doctor whether the patient should have additional imaging or blood tests done to figure out the exact cause of the stroke, since that might change which prevention medicine would work best.
What's New
PubMed · June 25, 2026
Researchers found that in people with a common heart rhythm problem called atrial fibrillation — where the heart beats irregularly — completely removing all the areas of damaged heart tissue during a procedure didn't overall lead to fewer episodes of the irregular rhythm compared to not targeting those areas at all. However, the study hinted that people whose heart's upper left chamber had grown larger over time might be more likely to benefit from the complete removal approach. This is early research and hasn't yet changed treatment guidelines.
What's New
PubMed · June 25, 2026
Researchers found that a procedure called pulsed field ablation — which uses precise bursts of electrical energy to treat irregular heart rhythms — worked better as a first-line treatment for a type of atrial fibrillation (an irregular heartbeat) than starting with medication alone. At 12 months, about 56% of people who had the procedure were doing well, compared to about 30% of those who started on medication. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient should consider pulsed field ablation as a first treatment instead of trying blood pressure or heart rhythm medications first for persistent atrial fibrillation.
What's New
PubMed · June 25, 2026
Researchers found that using an Apple Watch to monitor heart rhythm after a procedure to treat atrial fibrillation — an irregular heartbeat condition — may allow patients to take blood thinners only when the irregular rhythm is actually detected, rather than every single day. In this small study, that approach reduced the amount of time patients spent on blood thinners by about 95%, and no strokes or serious bleeding events occurred during the study period. This is early research and hasn't yet changed treatment guidelines.
Ask your doctor: Ask the doctor whether the patient could use an Apple Watch to monitor for atrial fibrillation after ablation surgery and stop blood thinner medication if no irregular heartbeats are detected, instead of taking the blood thinner continuously.
What's New
PubMed · June 25, 2026
Researchers found that for people with atrial fibrillation (an irregular heartbeat) who don't have diabetes, doing extra heart tissue treatment during a procedure called catheter ablation — where doctors use heat energy to correct the irregular heartbeat — helped prevent the irregular rhythm from coming back. However, in people who also had diabetes, that extra treatment didn't seem to provide the same benefit, with success rates looking similar whether or not it was performed. This is early research and hasn't yet changed treatment guidelines.
For informational purposes only. Not medical advice. Always consult a physician before making any health decisions.